Posted 23 July 2021
Patient centricity has long been at the heart of medical innovation, but today shapes its future.
Achieving patient centricity at scale: a holistic and data-driven approach
Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, announced the launch of its Achieving patient centricity at scale: a holistic and data-driven approach whitepaper.
Patient centricity is hardly a new concept for the life sciences industry, but it has never been more urgent or achievable than it is today.
Traditionally, pharmas, medtechs and diagnostics companies focused on serving the needs of other customers – physicians and payers. That was what moved sales volumes and ultimately funded the pipeline of future medical innovations. Understanding the patient experience and catering to patient needs was seen as a nice-to-have, a potential differentiator, but not an essential starting point for medical innovation.
We’re no longer living in a world in which a patient focus is optional. Converging trends in technology, drug development, the regulatory landscape and the commercial market for medicines are making a deep understanding of patients as people living complex lives mission-critical for biopharmas and medtechs today.
Download the whitepaper now: Achieving patient centricity at scale: a holistic and data-driven approach
Clarivate™ is a global leader in providing solutions to accelerate the lifecycle of innovation. Our bold mission is to help customers solve some of the world’s most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions in the areas of science and intellectual property. We help customers discover, protect and commercialise their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise. For more information, please visit clarivate.com.